Advertisement

Citation tools

Gotlib, Jason et al "A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis." Blood Advances 3.15 (2019): 2264-2271. Web. 25 Aug. 2019.